Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-021-01488-6, published online 22 July 2021
The original version of this article unfortunately contained an error. The labels were swapped in Figure 3a. The WT should be purple and the FGFR altered should be red. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rose, T.L., Weir, W.H., Mayhew, G.M. et al. Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience. Br J Cancer 126, 1237 (2022). https://doi.org/10.1038/s41416-022-01781-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-022-01781-y
